Track the 휴젤 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 휴젤 has published 44 insider filings. Market capitalisation: €2,652.2bn. The latest transaction was disclosed on 2 July 2026 (Sale). Among the most active insiders: 아프로디테애퀴지션홀딩스엘엘씨. All data is free.
39
Insider Decl.
n/a
Thresholds
€11,681
6 ops.
Buy Volume
n/a
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 휴젤 Strong Buy (bullish), based on 16 analysts. Average price target: ₩369,313.
23Σ signal
Buys €11,681n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,923 of 29,064 companies
73.8
score / 100
Value
59
Quality
89
FCF yld4.5%
Earn yld5.3%
EV/EBITDA12.3x
ROE17%
Gross mgn78%
Net mgn33%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
휴젤 es una empresa surcoreana que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se enfoca en el desarrollo y comercialización de productos farmacéuticos y dispositivos médicos.